CZR CAESARS ENTMT CORP

Ownership history in Bayesian Capital Management, LP  ·  15 quarters on record

This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in CAESARS ENTMT CORP (CZR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.32% (2021 Q4)
Avg. % of fund
0.14%
First filed
2018 Q2
Last filed
2025 Q3
Quarters held
15
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 13,857 +5,957 +75.4% 0.08% $374K $27.02
2024 Q4 REDUCED 7,900 -44,300 -84.9% 0.03% $264K $33.42
2024 Q3 ADDED 52,200 +46,000 +741.9% 0.26% $2.2M $41.74
2024 Q2 REDUCED 6,200 -13,494 -68.5% 0.03% $246K $39.74
2023 Q2 ADDED 19,694 +4,700 +31.3% 0.11% $1.0M $50.97
2023 Q1 REDUCED 14,994 -609 -3.9% 0.09% $732K $48.81
2022 Q4 ADDED 15,603 +4,803 +44.5% 0.09% $649K $41.60
2021 Q4 ADDED 10,800 +2,141 +24.7% 0.32% $1.0M $93.53
2021 Q3 ADDED 8,659 +2,459 +39.7% 0.28% $972K $112.28
2021 Q2 ADDED 6,200 +800 +14.8% 0.17% $643K $103.75
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CZR price (monthly, adj. close)
← Back to Bayesian Capital Management, LP Holdings